Eclevar MedTech Market Research Report
Company Overview
- Name: Eclevar MedTech
- Mission: Provide high-level clinical and regulatory solutions in the medtech industry.
- Founded: 2018
- Headquarters: Paris, France (with offices in UK, Germany, Australia, and Brazil)
- Key People:
- Chems Hachani, Chief Executive Officer
- Christophe Bourrilly, Chief Financial Officer
- Benedetto Sullivan, Head of Marketing
- Dr. Nikhil Khadabadi, Chief Medical Officer, Orthopedics and Spine
- Dr. Oscar Villarreal, Senior Clinical Consultant, and several others.
- Number of Employees: Over 100, according to indirect mentions of team size in services and operations.
- Revenue: No information is available.
- Known For: Offering comprehensive services for medical device clinical trials and regulatory compliance, focusing on advanced technologies and integration.
Products and Services
Eclevar MedTech operates as a Contract Research Organization (CRO) focusing on medical devices and therapeutic solutions across various areas, including:
- Medical Device Clinical Trial Suites:
- Cloud-based solutions that enhance the clinical trial process, offering patient engagement, interoperability with legacy systems, and modular technology for efficiency.
- Therapeutic Areas:
- Cardiovascular, Orthopedic, Spine, Diabetic Foot Ulcer, Ophthalmology, Dermatology, Oncology, and more.
- Key Features of Products:
- Site Qualification, Site Contracting, Patient Identification and Retention, Data Collection, and Enrollment strategies.
- Specialized in Regulatory Challenges related to medical devices with emphasis on compliance with EU MDR 745/2017.
Recent Developments
- New Partnerships:
- Collaboration with RegenLab to conduct PMCF studies for chronic diabetic foot ulcer devices, focusing on compliance with EU requirements.
- Partnership with ASAHI INTECC to provide consulting expertise in clinical evaluation for a Class III vascular catheter device.
- Enhancements and Innovations:
- Development and enhancement of the MILO Studio platform to manage global clinical studies effectively.
- Integration of advanced technologies in clinical trial processes to enhance efficiency and accuracy.
- Recognition:
- Eclevar was chosen as part of the UK government's initiative to promote innovation and high-growth industries and was granted the Crédit impôt recherche (CIR) in France.
- Positioned as part of "Jeunes Entreprises Innovantes" (Young Innovative Companies) in France.
Summary
Eclevar MedTech is a distinguished CRO that provides comprehensive clinical and regulatory support for the medtech industry. With their strategic global locales and emphasis on advanced technology use, Eclevar MedTech integrates seamlessly into the operational frameworks of medical device manufacturers aiming for regulatory compliance and enhanced market entry speed. Recent partnerships with medical device companies like RegenLab accentuate their commitment to innovation and quality improvement across therapeutic verticals.